A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKI

Name: A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKI
License: Public Domain

Peking University Cancer Hospital & Institute

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

renal cell carcinoma (rcc)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 424183
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.